Fulgent Genetics (MEX:FLGT) Other Current Liabilities : MXN62 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Fulgent Genetics Other Current Liabilities?

Fulgent Genetics's other current liabilities for the quarter that ended in Mar. 2024 was MXN62 Mil.

Fulgent Genetics's quarterly other current liabilities declined from Sep. 2023 (MXN5 Mil) to Dec. 2023 (MXN3 Mil) but then increased from Dec. 2023 (MXN3 Mil) to Mar. 2024 (MXN62 Mil).

Fulgent Genetics's annual other current liabilities declined from Dec. 2021 (MXN219 Mil) to Dec. 2022 (MXN103 Mil) and declined from Dec. 2022 (MXN103 Mil) to Dec. 2023 (MXN3 Mil).

Fulgent Genetics Other Current Liabilities Historical Data

The historical data trend for Fulgent Genetics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics Other Current Liabilities Chart

Fulgent Genetics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

Fulgent Genetics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Fulgent Genetics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Fulgent Genetics Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Fulgent Genetics's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Fulgent Genetics (MEX:FLGT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (MEX:FLGT) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

FLGT:USA 7F0:Germany

Address

4978 Santa Anita Avenue, Temple City, CA, USA, 91780

Website

https://www.fulgentgenetics.com

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.